US2007167445A1PendingUtilityA1
Androgen receptor modulator compounds and methods
Est. expiryAug 27, 2019(expired)· nominal 20-yr term from priority
Inventors:Robert I. HiguchiKristen L. ArientiNeelakandha S. ManiBarbara PioLin ZhiPenghui ChenThomas Raymond Caferro
A61P 35/00A61P 7/00A61P 5/24A61P 7/06A61P 5/00A61P 5/28A61P 5/26A61P 19/10A61P 17/10A61P 15/16A61P 17/14A61P 15/08A61P 15/10A61P 13/08C07D 498/14C07D 513/04C07D 471/04C07D 498/04
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Compounds, pharmaceutical compositions, and methods for modulating processes mediated by steroid receptors. In particular, preparation and methods of use of non-steroidal compounds and compositions that are agonists, partial agonists, and antagonists for the androgen receptor (AR) are described. Further, described are the methods of making and use of critical intermediates including a stereoselective synthetic route to intermediates for the AR modulators.
Claims
exact text as granted — not AI-modified1 . A compound having the formula:
wherein:
R x is selected from among C 1 -C 8 alkyl, C 3 -C 8 cycloalkyl, C 1 -C 8 heteroalkyl, C 1 -C 8 haloalkyl, allyl, aryl, arylalkyl, heteroaryl, C 2 -C 8 alkynyl, and C 2 -C 8 alkenyl, wherein the alkyl, cycloalkyl, heteroalkyl, haloalkyl, allyl, aryl, arylalkyl, heteroaryl, alkynyl, and alkenyl are optionally substituted with halogen, C 1 -C 4 alkyl, or C 1 -C 4 haloalkyl;
R 4 is selected from among hydrogen, C 1 -C 8 alkyl, C 3 -C 8 cycloalkyl, C 1 -C 8 heteroalkyl, C 1 -C 8 haloalkyl, aryl, arylalkyl, heteroaryl, C 2 -C 8 alkynyl, and C 2 -C 8 alkenyl, wherein the alkyl, cycloalkyl, heteroalkyl, haloalkyl, aryl, arylalkyl, heteroaryl, alkynyl, and alkenyl are optionally substituted with halogen, C 1 -C 4 alkyl, or C 1 -C 4 haloalkyl; and
R 13 is selected from among hydrogen, C 1 -C 8 alkyl, C 1 -C 8 heteroalkyl, C 1 -C 8 haloalkyl, C 3 -C 8 cycloalkyl, aryl, heteroaryl, arylalkyl, heteroarylalkyl, C 2 -C 8 alkynyl, and C 2 -C 8 alkenyl, wherein the alkyl, heteroalkyl, haloalkyl, cycloalkyl, aryl, heteroaryl, arylalkyl, heteroarylalkyl, alkynyl, and alkenyl groups are optionally substituted.
2 . A compound having the formula:
wherein:
R x is selected from among C 1 -C 8 alkyl, C 3 -C 8 cycloalkyl, C 1 -C 8 heteroalkyl, C 1 -C 8 haloalkyl, allyl, aryl, arylalkyl, heteroaryl, C 2 -C 8 alkynyl, and C 2 -C 8 alkenyl, wherein the alkyl, cycloalkyl, heteroalkyl, haloalkyl, allyl, aryl, arylalkyl, heteroaryl, alkynyl, and alkenyl are optionally substituted with halogen, C 1 -C 4 alkyl, or C 1 -C 4 haloalkyl;
R 4 is selected from among hydrogen, C 1 -C 8 alkyl, C 3 -C 8 cycloalkyl, C 1 -C 8 heteroalkyl, C 1 -C 8 haloalkyl, aryl, arylalkyl, heteroaryl, C 2 -C 8 alkynyl, and C 2 -C 8 alkenyl, wherein the alkyl, cycloalkyl, heteroalkyl, haloalkyl, aryl, arylalkyl, heteroaryl, alkynyl, and alkenyl are optionally substituted with halogen, C 1 -C 4 alkyl, or C 1 -C 4 haloalkyl;
R 6 is selected from among hydrogen, C 1 -C 8 alkyl, C 3 -C 8 cycloalkyl, C 1 -C 8 heteroalkyl, C 1 -C8 haloalkyl, aryl, arylalkyl, heteroaryl, C 2 -C 8 alkynyl, and C 2 -C 8 alkenyl, wherein the alkyl, cycloalkyl, heteroalkyl, haloalkyl, aryl, arylalkyl, heteroaryl, alkynyl, and alkenyl are optionally substituted with halogen, C 1 -C 4 alkyl, or C 1 -C 4 haloalkyl; and
R 13 is selected from among hydrogen, C 1 -C 8 alkyl, C 1 -C 8 heteroalkyl, C 1 -C 8 haloalkyl, C 3 -C 8 cycloalkyl, aryl, heteroaryl, arylalkyl, heteroarylalkyl, C 2 -C 8 alkynyl, and C 2 -C 8 alkenyl, wherein the alkyl, heteroalkyl, haloalkyl, cycloalkyl, aryl, heteroaryl, arylalkyl, heteroarylalkyl, alkynyl, and alkenyl groups are optionally substituted.
3 . A compound having the formula:
wherein:
R 6 is selected from among hydrogen, C 1 -C 8 alkyl, C 3 -C 8 cycloalkyl, C 1 -C 8 heteroalkyl, C 1 -C 8 haloalkyl, aryl, arylalkyl, heteroaryl, C 2 -C 8 alkynyl, and C 2 -C 8 alkenyl, wherein the alkyl, cycloalkyl, heteroalkyl, haloalkyl, aryl, arylalkyl, heteroaryl, alkynyl, and alkenyl are optionally substituted with halogen, C 1 -C 4 alkyl, or C 1 -C 4 haloalkyl;
R 7 is selected from among hydrogen, C 1 -C 8 alkyl, C 3 -C 8 cycloalkyl, C 1 -C 8 heteroalkyl, C 1 -C 8 haloalkyl, aryl, arylalkyl, heteroaryl, C 2 -C 8 alkynyl, and C 2 -C 8 alkenyl, wherein the alkyl, cycloalkyl, heteroalkyl, haloalkyl, aryl, arylalkyl, heteroaryl, alkynyl, and alkenyl are optionally substituted with halogen, C 1 -C 4 alkyl, or C 1 -C 4 haloalkyl; and
R 13 is selected from among hydrogen, C 1 -C 8 alkyl, C 1 -C 8 heteroalkyl, C 1 -C 8 haloalkyl, C 3 -C 8 cycloalkyl, aryl, heteroaryl, arylalkyl, heteroarylalkyl, C 2 -C 8 alkynyl, and C 2 -C 8 alkenyl, wherein the alkyl, heteroalkyl, haloalkyl, cycloalkyl, aryl, heteroaryl, arylalkyl, heteroarylalkyl, alkynyl, and alkenyl groups are optionally substituted.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.